Sign In
Buy STXS
$1.84
-0.130 (-6.60%)
At Close: Jun 03, 2026
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
04:02pm, Monday, 13'th May 2024
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has ent
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
07:51am, Monday, 22'nd Apr 2024
ST. LOUIS, April 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
06:00am, Friday, 19'th Apr 2024
Let's just get something straight off the bat – penny stocks to rebound are risky. They're incredibly treacherous in terms of both short-term downside and longer-term damage to your portfolio.
7 Penny Stocks That Could 5X by the End of 2024
09:22am, Wednesday, 10'th Apr 2024
Penny stocks could be your ticket to striking it rich. But don't expect easy money!
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
02:58pm, Sunday, 17'th Mar 2024
Generally speaking, you want to minimize your exposure to cheap stocks under $10. Yes, smaller companies have the potential to rise dramatically higher than their larger counterparts.
Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months
12:58am, Saturday, 09'th Mar 2024
Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months
Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter
08:50am, Friday, 08'th Mar 2024
Stereotaxis (STXS) announces the regulatory submissions of its MAGiC catheter in Europe and the United States, which are intended for use in minimally invasive cardiac ablation treatments.
Stereotaxis, Inc. (STXS) Q4 2023 Earnings Call Transcript
06:57pm, Monday, 04'th Mar 2024
Stereotaxis, Inc. (NYSE:STXS ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants David Fischel - Chairman and CEO Kimberly Peery - CFO Conference Call Participants Frank T
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
04:06pm, Monday, 04'th Mar 2024
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that regulato
Stereotaxis Reports 2023 Full Year Financial Results
04:05pm, Monday, 04'th Mar 2024
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial resu
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
04:15pm, Thursday, 22'nd Feb 2024
ST. LOUIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the first treatment of patients
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
09:05am, Tuesday, 20'th Feb 2024
ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will r
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
08:34am, Monday, 08'th Jan 2024
ST. LOUIS, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have bee
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
08:42am, Tuesday, 28'th Nov 2023
LEXINGTON, Ky. and ST. LOUIS, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, and Baptist Health Lexington,
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference
08:54am, Monday, 20'th Nov 2023
ST. LOUIS, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fis
